secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenland Mines Ltd (GRML)
CIK:        0001907223
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001213900-24-071578
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ANEW Medical appoints CFO LeBlanc ($325k base) and COO Moriarty ($300k base) effective Aug 15
--------------------------------------------------------------------------------

- Jeffrey LeBlanc appointed CFO effective Aug 15, 2024; 3-year term, base salary $325k, initial 100k shares + 400k shares vesting over 2 years.
- Peter Moriarty appointed COO effective Aug 15, 2024; 3-year term, base salary $300k, initial 100k shares + 400k shares vesting over 2 years.
- LeBlanc has 20+ years finance experience, co-founded SPAC Winvest (WINV), earlier roles at Greenlight Capital, GE Capital, McKinsey.
- Moriarty co-founded Shire Pharmaceuticals (acquired by Takeda), led Prismic Pharma, and has extensive pharma industry experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907223/000121390024071578/0001213900-24-071578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907223/000121390024071578/ea0212103-8k_anewmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer